Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

This repository is under review for potential modification in compliance with Administration directives.

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

Development Status

Other

5,096

Investigational

784

Possibly Marketed Outside US

383

US Approved Rx

300

US Previously Marketed

77

All Match

Any Match

Exclude Selected

Exclude Selected

Primary Target

Dopamine D2 receptor

42

Histamine H1 receptor

34

Serotonin 2a (5-HT2a) receptor

33

Acetylcholinesterase

25

DNA topoisomerase I

23

All Match

Any Match

Exclude Selected

Exclude Selected

Highest Phase

Approved

397

Phase II

78

Phase III

49

Phase I

40

Not Provided

27

All Match

Any Match

Exclude Selected

Exclude Selected

Approval Year

Unknown

6,109

2013

28

1996

25

1921

23

2020

20

All Match

Any Match

Exclude Selected

Exclude Selected

Condition

Unknown

127

Cancer

61

Depression

39

Schizophrenia

37

Alzheimer’s disease

34

All Match

Any Match

Exclude Selected

Exclude Selected

Treatment Modality

Primary

598

Curative

110

Palliative

73

Preventing

44

Diagnostic

29

All Match

Any Match

Exclude Selected

Exclude Selected

CNS Activity

CNS Active

229

CNS Penetrant

158

CNS Non-penetrant

60

All Match

Any Match

Exclude Selected

Exclude Selected

Originator

Eli Lilly

23

Bayer

21

GlaxoSmithKline

21

Merck

18

Bristol-Myers Squibb

12

All Match

Any Match

Exclude Selected

Exclude Selected

Substance Class

Chemical

5,843

Protein

354

Structurally Diverse

318

Mixture

85

Polymer

53

All Match

Any Match

Exclude Selected

Exclude Selected

INN Stem

Monoclonal antibodies(-mab)

14

Tyrosine-kinase inhibitors(-tinib)

12

Chemical substance(-ine)

8

Gene Therapy vectors(-vec)

6

Antiviral drug(-vir)

4

All Match

Any Match

Exclude Selected

Exclude Selected

GInAS Tag

KEW

2

All Match

Any Match

Exclude Selected

Exclude Selected

Code System

FDA UNII

6,700

CAS

5,943

PUBCHEM

5,653

EPA CompTox

3,622

SMS_ID

1,312

All Match

Any Match

Exclude Selected

Exclude Selected

Protein Type

MONOCLONAL ANTIBODY

42

MONOCLONAL ANTIBODY CONJUGATE

29

RECEPTOR

27

BISPECIFIC ANTIBODY

22

ENZYME

20

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 1

NERVOUS SYSTEM

44

ALIMENTARY TRACT AND METABOLISM

34

SENSORY ORGANS

31

ANTIINFECTIVES FOR SYSTEMIC USE

29

DERMATOLOGICALS

27

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 2

OPHTHALMOLOGICALS

30

ANTINEOPLASTIC AGENTS

18

PSYCHOLEPTICS

17

ANTIBACTERIALS FOR SYSTEMIC USE

15

PSYCHOANALEPTICS

15

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 3

ANTIDEPRESSANTS

13

ANTIINFECTIVES

12

ANTIPSYCHOTICS

12

OTHER ANTINEOPLASTIC AGENTS

11

STOMATOLOGICAL PREPARATIONS

7

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 4

Non-selective monoamine reuptake inhibitors

13

Antibiotics

8

Other antineoplastic agents

7

Antiinfectives

6

Diazepines, oxazepines, thiazepines and oxepines

5

All Match

Any Match

Exclude Selected

Exclude Selected

Substance Form

Principal Form

5,908

Salts, Hydrates, Esters, etc.

792

All Match

Any Match

Exclude Selected

Exclude Selected

Search results for amphotericin root_names_stdName in Standardized Name (approximate match)

Showing 6061 - 6070 of 6,711 results

First page
Previous page
Next page
Next page

Loading ...

NaN

Showing 6061 - 6070 of 6,711 results

First page
Previous page
Next page
Next page

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1